summARY The serum concentration of prolactin is frequently increased after single epileptic seizures and has therefore been used as a method to differentiate between hysterical attacks and epileptic seizures. We determined plasma prolactin concentrations in fifteen patients with status epilepticus. Seven 
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Results
Baseline values and ictal levels of serum prolactin for the fifteen patients are shown in the table. All ictal prolactin concentrations were within the normal range. The ictal prolactin level was lower than the baseline value in most patients. Patient 8 had an abnormally high baseline prolactin concentration. This may be explained by the fact that this patient was given 300 mg of thioridazine daily immediately after the status and before the baseline sampling for the treatment of a psychosis. This drug is known to induce hyperprolactinaemia.
Discussion
The clinical features of generalised tonic-clonic status epilepticus are generally easily recognised, and effective treatment is given before EEG verification. This is the evident explanation for the underrepresentation of the convulsive forms of status epilepticus among the thirteen patients with ictal EEG recordings. To increase the number ofpatients with generalised tonicclonic status, we included two patients with clinically indisputable tonic-clonic status epilepticus, despite the lack ofEEG verification. Among cases of non-convulsive status, only patients with focal ictal seizure activity were classified as cases of complex partial status. All patients with non-focal seizure activity were designated as absence status. Generalised epileptiform discharges could, however, also represent complex partial status in which the generalised discharges are originating from an epileptic focus.'3"" Some of our patients, classified as cases of absence status, may therefore represent complex partial status with secondary generalised EEG discharges.
Seven patients were classified as having absence status. Prolactin secretion after single absence seizures has previously been reported in only a few patients.'12 Serum prolactin has consistently been normal and unchanged from baseline levels. It has been postulated that this is due to the different nature of the epileptic discharge or that there may not be a spread of the paroxysmal activity to hypothalamic neurons in absence seizures.2 The lack of effect on serum prolactin, however, may also be due to the short duration of single absences. Thus, the serum levels of prolactin are normal both after short single absences and in connection with absence status epilepticus. Whether or not there is a rise in serum prolactin after absence seizures of intermediate duration remains to be investigated.
Serum prolactin during status epilepticus
Serum prolactin was within the normal range also in all cases of complex partial and generalised tonicclonic status. It is thus obvious that serum prolactin concentrations cannot be used as a biochemical marker to distinguish between epileptic and nonepileptic attacks in connection with status epilepticus. All our patients, who represent three different types of status epilepticus, had ictal prolactin levels within the normal range and there was no increase from baseline values. To our knowledge, this is the first published systematic study of prolactin secretion during status epilepticus. However, in a study of 23 patients with various seizures, Bye et al' included three patients with so called minor epileptic status. The term was used for severe repetitive myoclonic attacks. A significant increase in prolactin concentrations was found in only one of the three patients.
Jackel et al 7 studied a patient who had three complex partial seizures in six hours. They found a decreased prolactin response with repetitive seizures. A reduced prolactin release with repeated seizures is consistent with our observations in status epilepticus. Ictal prolactin concentrations were in fact lower than baseline levels in most of our patients, and in thirteen of the patients they were in the lower part of the normal range. Patient 9, who had the highest ictal prolactin concentration, was also the patient with the shortest duration of her status. The length of the seizure is apparently crucial for the prolactin concentration. Previous studies have shown that there is generally no rise in serum prolactin after brief attacks of less than about 30 seconds." Our study shows that there is no increase in prolactin levels after protracted seizure activity as in status epilepticus of two hours or more.
Benzodiazepines were given to all patients in order to terminate the status. One may therefore speculate if this may have influenced the prolactin levels. However, diazepam, which was used in fourteen ofthe fifteen patients, has been shown not to affect serum prolactin concentrations.'8 Furthermore, the prolactin samples were obtained before benzodiazepine treatment in most patients.
The prolactin increase induced by epileptic seizures could be due to the spread of electrical activity to the hypothalamic nuclei resulting in a secretion of prolactin. 3 
